Erythropoietin and the pro-inflammatory cytokines in chronic C hepatitis

Hepato-Gastroenterology

Volumn 56, Issue 91-92, 2009, Pages 751-755

  Mihǎilǎ, Romeo Gabriel ^a,c   Rezi, Elena Cristina ^b   Boitan, Minerva ^a   Zaharie, Alina Viorica ^b   Olteanu, Ariela ^b   Deac, Mircea ^d  

^a LUCIAN BLAGA UNIVERSITY OF SIBIU   (Romania)

^b Sibiu Clinical County Hospital   (Romania)

^c Spitalul Clinic Judetean de Urgenta Cluj   (Romania)

^d NONE

Author keywords

C reactive protein; Chronic renal failure; Erythropoietin; Hemodialysis; Hepatitis C virus; Interleukin 6; Interleukin 8; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; ERYTHROPOIETIN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; ERYTHROPOIETIN; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 67651229817     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Falck-Ytter Y, Kale H, Mullen KD, Sarbah SA, Sorescu L, McCullough AJ: Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002; 136:288-292.
2. Powell EE, Edward-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, et al: Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31:828-833. (Pubitemid 30169926)
3. Lonardo A, Loria P, Adinolfi LE, Carulli N, Ruggiero G: Hepatitis C and steatosis: A reappraisal. J Viral Hepat 2006; 13:73-80.
4. Vignau J, Karila L, Costisella O, Canva V: Hepatitis C, interferon a and depression: main physiopathologic hypothesis. Rncephale 2005; 31:349-357. (Pubitemid 41024651)
5. Collier JD, Woodall T, Wight DGD, Shore S, Gimson AE, Alexander GJM: Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection. J Viral Hepat 2005; 12:74-80. (Pubitemid 40188777)
6. Sasaki R, Masuda S, Nagano M: Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiol Sci 2001; 16:110-113. (Pubitemid 33570297)
7. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH: Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 2002; 64:326-333.
8. Maiese K, Li F, Chong ZZ: New avenues of exploration for erythropoietin. JAMA 2005; 293:90-95.
9. Borawski J, Naumnik B, Mysliwiec M: Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy. Clin Appl Thromb Hemost 2002; 8:359-367. (Pubitemid 36008760)
10. Gutierrez-Reyes G, Lopez-Ortal P, Sixtos S, Cruz S, Ramirez-Iglesias MT, Gutierrez-Ruiz MC, et al: Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C. Scand J Immunol 2006; 63:461-467. (Pubitemid 43978861)
11. Hassan M, Selimovic D, Ghozlan H, Abdel-Kader O: Induction of high-molecular-weight tumor necrosis factor alpha by hepatitis C virus non-structural protein 3 in liver cells is AP-1 and NF-kappaB-dependent activation. Cell Signal 2007; 19:301-311. (Pubitemid 44969979)
12. Kasprzak A, Seidel J, Spachacz R, Biczysko W, Markowska A, Kaczmarek E, et al: Intracellular expression of pro-inflammatory cytokines (IL-1 alpha, TNF-alpha, and IL-6) in chronic hepatitis C. Rocz Akad Med Bialymst 2004; 49 Suppl1:207-209.
13. Knobler H, Schattner A: TNF-alpha, chronic hepatitis C and diabetes: a novel triad. QJM 2005; 98:1-6.
14. Jia HY, Du J, Zhu SH, Ma YJ, Chen HY, Yang BS, et al: The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int 2002; 1:378-382. (Pubitemid 36748769)
15. Romero-Gómez M: Hepatitis C and insulin resistance: steatosis, fibrosis and nonresponse. Rev Esp Enferm Dig 2006; 98:605-615. (Pubitemid 350259157)
16. Crespo J, Rivero M, Fábrega E, Cayón A, Amado JA, García-Unzeta MT, et al: Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis. Dig Dis Sci 2002; 47:1604-1610. (Pubitemid 34753942)
17. Falasca K, Ucciferri C, Dalessandro M, Zingariello P, Mancino P, Petrarca C, et al: Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 2006; 36:144-150.
18. Migita K, Abiru S, Maeda Y, Daikoku M, Ohata K, Nakamura M, et al: Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol 2006; 67:27-32.
19. Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J: Polymorphism in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol 2003; 71:212-218. (Pubitemid 37048464)
20. Tachibana Y, Nakamoto Y, Mukaida N, Kaneko S: Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C. Cancer Lett 2007; 251:36-42. (Pubitemid 46589764)
21. Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, Iannelli A, et al: The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH. Am J Gastroenterol 2006; 101:1824-1833. (Pubitemid 44166593)
22. Taliani G, Badolato MC, Nigro MC, Biasin M, Boddi V, Pasquazzi C, et al: Serum concentration of gammaGT is a surrogate marker of hepatic TNF-alpha mRNA expression in chronic hepatitis C. Clin Immunol 2002; 105:279-285. (Pubitemid 36016055)
23. Szczepanski M, Kamianowska M, Wnuczko K, Skrtydlewska E, Wonczynski S: Erythropoietin prevents oxidative stress and lipid peroxidation process in human umbilical vein endothelial cells induced by tumor necrosis factor alpha. Pol Merkur Lekarski 2006; 21:534-539.
24. Schmeding M, Neumann UP, Boas-Knoop S, Spinelli A, Neuhaus P: Erythropoietin reduces ischemia-reperfusion injury in the rat liver. Eur Surg Res 2007; 39:189-197. (Pubitemid 46633182)
25. Pirisi M, Fabris C, Falleti E, Soardo G, Toniutto P, Gonano F, et al: Evidence for a multifactorial control of serum erythropoietin concentration in liver disease. Clin Chim Acta 1993; 219:47-55. (Pubitemid 23332660)
26. Tacke F, Schöffski P, Luedde T, Meier PN, Ganser A, Manns MP, et al: Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand J Gastroenterol 2004; 39:259-266. (Pubitemid 38388871)